explore -WSS

explore

author：knowledge 2025-10-02 20:06:23 - browse：5669

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Medicare Advantage insurers pressure Biden for bigger payments

focus

WSS

Covid hospitalizations on the rise, Humana says

Biotech investment managers search for lucrative opportunities

How generative AI is inspiring dreams of a health data revolution

Snackable artificial intelligence, expert AI, and the pharma industry

AstraZeneca chief proposes a novel edit to the drug pricing bill

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

focus

explore

focus

Novavax promises a turnaround & Lilly roils the obesity market

'Make People Better': The CRISPR babies story you probably don't know

Drug repurposing or repositioning? The language matters

Amazon on where the company's health care bets are headed next

Hepatitis C has a cure — but many Americans still lack access to it

Humana sues Biden admin over Medicare Advantage audit rule

Heart attack and stroke risk calculators need revising

Cancer, immunology, HIV research ensnared in fetal tissue politics

Jerome Adams on the need for new antivirals for Covid

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

focus

Erich Jarvis studies song birds to learn about human stuttering

Asbestos ban is immediate, but health effects will linger for decades

Advances in CAR

Crinetics acromegaly drug succeeds in late

The (many) problems with a new study criticizing cancer screening

Medical devices makers are asking for forgiveness, not permission

focus

explore

entertainment

hotspot